...
首页> 外文期刊>Clinical chemistry and laboratory medicine: CCLM >Implementing the Stockholm Conference hierarchy of objective quality criteria in a routine laboratory.
【24h】

Implementing the Stockholm Conference hierarchy of objective quality criteria in a routine laboratory.

机译:在常规实验室中实施斯德哥尔摩会议客观质量标准的层次结构。

获取原文
获取原文并翻译 | 示例

摘要

BACKGROUND: Analytical performance of clinical laboratory testing should be evaluated against objective quality specifications. The Stockholm Conference consensus recommendation states that from a hierarchy of quality models, the highest-ranking model should be used. This study reports the performance of a routine clinical laboratory using these quality recommendations. Quality standards recommended for use in manufacturers' package inserts are also compared against the objective criteria. METHODS: Imprecision of 22 analytes was monitored by analyzing three levels of commercial quality control (QC) material daily over a 6-month period. The performance for each analyte was evaluated against defined quality specifications based on biological variation and the National Cholesterol Education Panel (NCEP) criteria. RESULTS: Overall, objective quality specifications were met by the laboratory for 18/22 (82%) analytes. The performance for analytes not meeting the criteria was assessed against quality targets based on a model lower in the hierarchy, i.e., interlaboratory imprecision data derived from an accredited EQA program. All analytes met these quality targets. When quality targets set by the manufacturer were applied to biological variation and NCEP criteria, results for only 8/22 (36%) analytes met the targets. CONCLUSIONS: Objective quality specifications can be consistently achieved in a routine laboratory. The hierarchy model of the Stockholm Conference should be promoted for global adoption.
机译:背景:临床实验室测试的分析性能应根据客观质量规范进行评估。斯德哥尔摩会议的共识建议指出,从质量模型的层次结构来看,应该使用排名最高的模型。这项研究报告了使用这些质量建议的常规临床实验室的性能。还将推荐用于制造商包装插页的质量标准与客观标准进行比较。方法:通过在六个月的时间内每天分析三种水平的商业质量控制(QC)材料,监测22种分析物的不精确度。根据生物变异和美国国家胆固醇教育小组(NCEP)的标准,根据定义的质量规格对每种分析物的性能进行了评估。结果:实验室满足了18/22(82%)分析物的总体客观质量要求。根据等级较低的模型(即,从认可的EQA程序获得的实验室间不精确数据),针对质量目标评估了不符合标准的分析物的性能。所有分析物均达到了这些质量目标。当将制造商设定的质量目标应用于生物学变异和NCEP标准时,只有8/22(36%)的分析物的结果达到了目标。结论:可以在常规实验室中始终如一地实现客观的质量规格。应当推广斯德哥尔摩会议的层次模型以供全球采用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号